Search
aTyr Pharma Ord Shs
LIFEAdd to Watchlist
40.880USD
-1.740-4.08%
Close 11-02 16:00（ET）
2.66BMarket Cap
LossP/E TTM
After-hours 18:29 (ET)40.270USD-0.430-1.06%
After-hours 18:29 (ET)Today
-4.08%
5 Days
-3.36%
1 Month
+19.81%
6 Months
+119.20%
Year to Date
+1249.17%
1 Year
+1249.17%
Key Figures
49.980Open
48.350High
545.48KVolume
LossP/E TTM
17.03P/E Dynamic
--Dividend TTM
0.84%Turnover Ratio
42.620Prev. Close
40.220Low
23.58MTurnover
LossP/E Static
5.59P/B
0.00%Div Yield TTM
-75.78%ROA
48.35052wk High
0.34Volume Ratio
-64.02MNet Profit
64.98MShares
-2.6328EPS TTM
--Beta
-103.22%ROE
1.67052wk Low
19.08%Amplitude
97.06%Gross Margin
2.66BMarket Cap
13.95Reward/Risk
29.31%Risk Rate
aTyr Pharma Ord Shs's Score
0.05vs previous score
Forecast8.67
Financial Health8.22
Technical5.31
Valuation Dimensions8.81
Institutional Confidence7.00
Risk Assessment4.02
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
aTyr Pharma Ord Shs Technical Analysis
Technical Indicators
Strong sell
Summary
Neutral
Moving Average
Buy
aTyr Pharma Ord Shs Latest Earnings Call Transcripts
Ethos Technologies (LIFE) Fiscal Q3 2026 Earnings Call: Revenue Jumps 151%, Guidance Raised
Ethos Technologies Q3 2026 earnings call: revenue rose 151% to $235 million, adjusted EBITDA reached $35 million, and full-year guidance increased.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/0.30
Revenue / Forecast
--/165.76M
aTyr Pharma Ord Shs Profile
SectorBiotechnology & Medical Research
Ticker SymbolLIFE
Number of employees0
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Alphabet, Inc. | 12.20% |
| SB Global Advisers Ltd | 10.12% |
| Capital Research Global Investors | 4.26% |
| T. Rowe Price Investment Management, Inc. | 2.98% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 23.46% |
| Venture Capital | 12.20% |
| Individual Investor | 6.29% |
| Investment Advisor/Hedge Fund | 1.43% |
Related Instruments
-0.11%
-1.62%
-0.98%
-2.49%
-1.40%
-1.45%
-0.90%
-1.68%
-0.64%
-2.18%
-4.05%
-2.08%
+0.12%
-0.48%
+1.26%
-0.88%
+3.45%
-0.57%
-0.55%
+2.99%
FAQs
What is the current price of aTyr Pharma Ord Shs (LIFE)?
The current price of aTyr Pharma Ord Shs (LIFE) is 42.62.
What is the symbol of aTyr Pharma Ord Shs?
The ticker symbol of aTyr Pharma Ord Shs is LIFE.
What is the 52-week high of aTyr Pharma Ord Shs?
The 52-week high of aTyr Pharma Ord Shs is 44.99.
What is the 52-week low of aTyr Pharma Ord Shs?
The 52-week low of aTyr Pharma Ord Shs is 1.67.
What is the market capitalization of aTyr Pharma Ord Shs?
The market capitalization of aTyr Pharma Ord Shs is 2.77B.
Is aTyr Pharma Ord Shs (LIFE) currently rated as Buy, Hold, or Sell?
According to analysts, aTyr Pharma Ord Shs (LIFE) has an overall rating of Buy, with a price target of 37.57.
What is the Earnings Per Share (EPS TTM) of aTyr Pharma Ord Shs (LIFE)?
The Earnings Per Share (EPS TTM) of aTyr Pharma Ord Shs (LIFE) is -2.63.